Adicet Bio Inc ACET 深沪

等待开盘 03-26 09:30:00 美东时间

6.765

+0.075

+1.12%

华盛通

立即下载

最高7.00
今开6.72
成交量 3.35万股
最低 6.72
昨收 6.69
总市值 6491.96万
52周最高 17.4384
市盈率 ^静 --
换手率 0.35%
52周最低 6.4066
委比 -60.00%
总股本 959.64万
历史最高 3606.40
量比 0.40
振幅 4.19%
历史最低 6.4066
每手 1
风险率 2.32%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元

今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元

03-24 10:07
HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $50 to $27.

03-23 19:23
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级

今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元

03-16 18:19
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the price target from $128 to $100.

03-13 20:52
Adicet Bio Files Prospectus To Offer Up To $250M In Common Stock

-SEC Filing

03-13 05:23
Adicet Bio GAAP EPS of -$2.94

Adicet Bio press release (ACET): FY GAAP EPS of -$2.94. Net Loss: Net loss for the three months ended December 31, 2025 was $30.5 million, or a net loss of $2.94 per basic and diluted share, including...

03-13 04:52
Adicet Bio Q4 EPS $(2.94) Beats $(3.10) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(2.94) per share which beat the analyst consensus estimate of $(3.10) by 5.04 percent. This is a 42.58 percent increase over losses of $(5.12) per share from the

03-13 04:02
Adicet Bio CEO to Present at Guggenheim Emerging Outlook Biotech Summit

Adicet Bio CEO to Present at Guggenheim Emerging Outlook Biotech Summit Adicet Bio, Inc., a clinical stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026.

01-30 20:00
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元

01-22 15:09
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $50

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $9 to $50.

01-21 19:33

派息除权日	每股总股息	派息日期
2018-09-21	0.010	2018-10-09
2018-06-07	0.010	2018-06-22
2018-03-08	0.06	2018-03-23
2017-12-15	0.06	2017-12-28
2017-09-07	0.06	2017-09-21
2017-06-07	0.06	2017-06-23
2017-03-08	0.06	2017-03-24
2016-12-08	0.06	2016-12-22
2016-09-07	0.06	2016-09-20
2016-06-07	0.06	2016-06-24
2016-03-09	0.06	2016-03-25
2015-12-15	0.06	2015-12-28
2015-09-17	0.06	2015-10-02
2015-06-09	0.06	2015-06-25
2015-03-10	0.06	2015-03-26
2014-12-11	0.06	2014-12-29
2014-09-11	0.06	2014-09-29
2014-06-10	0.06	2014-06-27
2014-03-11	0.06	2014-03-28
2013-12-12	0.06	2013-12-27
2013-09-12	0.06	2013-09-27
2013-06-12	0.05	2013-06-25
2013-03-13	0.05	2013-03-26
2012-12-13	0.05	2012-12-28
2012-09-13	0.05	2012-09-28
2012-06-07	0.10	2012-06-22
2011-12-23	0.10	2012-01-18
2011-06-09	0.10	2011-06-24
2010-12-22	0.10	2011-01-21
2010-06-10	0.10	2010-06-25
2009-12-22	0.10	2010-01-15
2009-06-11	0.10	2009-06-26
2008-12-17	0.10	2009-01-13
2008-06-12	0.10	2008-06-27
2008-02-20	0.05	2008-03-07
2007-12-19	0.10	2008-01-11
2007-06-14	0.10	2007-06-28
2006-12-20	0.08	2007-01-12
2006-06-15	0.08	2006-06-29
2005-12-21	0.08	2006-01-11
2005-06-16	0.08	2005-06-30
2004-12-21	0.11	2005-01-10
2004-06-10	0.09	2004-06-25
2003-12-15	0.13	2004-01-02
2003-06-12	0.12	2003-06-27
2002-12-16	0.17	2003-01-02
2002-06-13	0.16	2002-06-28
2001-12-17	0.16	2002-01-02
2001-06-14	0.16	2001-06-29
2000-12-15	0.15	2001-01-02
2000-06-15	0.15	2000-06-29
1999-12-16	0.15	2000-01-03
1999-06-11	0.13	1999-06-29
1998-12-17	0.13	1999-01-04
1998-06-12	0.13	1998-06-30
1998-06-10	0.13	1998-06-30
1997-12-15	0.18	1998-01-05
1997-06-12	0.18	1997-06-30
1996-12-12	0.18	1997-01-02
1996-06-13	0.18	1996-06-28
1995-12-14	0.20	1996-01-02
1995-06-15	0.18	1995-06-29
1994-12-12	0.18	1995-01-03
1994-06-14	0.16	1994-06-29
1993-12-13	0.16	1994-01-03
1993-06-15	0.14	1993-06-29
1992-12-14	0.17	1993-01-01
1992-06-16	0.14	1992-06-30
1991-12-09	0.14	1992-01-02
1991-06-04	0.14	1991-06-28
1990-12-10	0.14	1991-01-01
1990-06-05	0.07	1990-07-01
1989-11-27	0.50	1989-12-15
1989-06-06	0.07	1989-07-01
1988-12-12	0.07	1989-01-01
1988-10-24	0.50	1988-11-10
1988-06-07	0.07	1988-07-01
1988-03-30	1.25	1988-04-14
1987-12-15	0.07	1988-01-04
1987-06-08	0.07	1987-07-01
1986-10-07	0.07	1986-10-29
1986-03-24	0.07	1986-04-25
1985-10-22	0.07	1985-11-01
1984-10-02	0.04	1984-10-26
1984-03-26	0.04	1984-04-27
1983-10-04	0.04	1983-10-28
1983-03-28	0.04	1983-04-29
1982-10-05	0.04	1982-10-29
1982-03-30	0.03	1982-04-30
1981-10-06	0.03	1981-10-30
1981-03-31	0.03	1981-05-01
1980-10-07	0.03	1980-10-31
1980-03-30	0.10	1980-05-02
1979-09-30	0.03	1979-11-01
1978-12-10	0.05	1979-01-04
1978-01-08	0.05	1978-01-30
1976-12-27	0.05	1977-01-27
1975-12-25	0.05	1976-01-22

公司名称	Adicet Bio Inc
行业分类	制药
业务描述	Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of 'off-the-shelf' gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Adicet Bio Inc ACET 深 沪

6.765

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Adicet Bio Inc ACET 深沪